V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016428 | 160008149 | 1.65 | 71.8 | Palliative (P) | 2017-08-23 | 2018-04-19 | Cisplatin + Pemetrexed | 02 | null | CISPLATIN + PEMETREXED | 101731054 |
| 160016429 | 160008150 | 1.62 | 69.5 | Palliative (P) | 2017-04-12 | 2017-04-26 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100736808 |
| 160016430 | 160008151 | null | null | Palliative (P) | 2020-07-31 | 2020-08-10 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101052599 |
| 160016431 | 160008152 | 1.65 | 100 | Palliative (P) | 2018-03-31 | 2018-04-15 | EW EuroEwing 2012 Arm B VDC | 02 | N | IMATINIB | 100281697 |
| 160016432 | 160008153 | 1.58 | 61.6 | null | 2017-12-11 | 2017-12-18 | ETOP 13-18 BEAT-meso Trial | 02 | null | NB HRNBL-1 COJEC IND COURSE C | 101507553 |
| 160016438 | 160008154 | 1.53 | 72.4 | Palliative (P) | 2017-10-13 | 2017-10-18 | Carboplatin + Paclitaxel (3 weekly) | Y | N | CARBOPLATIN + PACLITAXEL | 101055507 |
| 160016440 | 160008155 | 1.62 | 59 | null | 2016-11-05 | 2016-11-19 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100907107 |
| 160016442 | 160008156 | 1.63 | 56.8 | Curative (C) | 2019-08-25 | 2019-08-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101327979 |
| 160016443 | 160008157 | 1.54 | 77.6 | Palliative (P) | 2019-10-26 | 2019-11-13 | Carboplatin + Paclitaxel (weekly) | N | N | CARBOPLATIN + PACLITAXEL | 100961692 |
| 160016444 | 160008158 | 1.78 | 83.1 | Palliative (P) | 2019-01-04 | 2019-01-18 | Liposomal Doxorubicin (Caelyx) | 02 | N | CAPECITABINE | 100920605 |
| 160016445 | 160008159 | null | null | Neo-adjuvant (N) | 2019-08-16 | 2019-08-22 | BENDAMUSTINE + RITUXIMAB | N | null | BENDAMUSTINE + RITUXIMAB | 101865166 |
| 160016447 | 160008160 | null | null | Palliative (P) | 2016-09-03 | 2018-12-03 | Liposomal Doxorubicin (Caelyx) | 02 | N | CARBOPLATIN + ETOPOSIDE | 101003237 |
| 160016448 | 160008161 | 1.73 | 76.6 | Palliative (P) | 2016-08-26 | 2016-08-26 | Doxorubicin + Olaratumab | 02 | Y | LIPOSOMAL DOXORUBICIN | 100743955 |
| 160016451 | 160008162 | 1.72 | 99.2 | null | 2016-09-24 | 2016-09-25 | Doxorubicin + Ifosfamide | N | N | CARBOPLATIN | 101331193 |
| 160016452 | 160008163 | 1.78 | 67.5 | Palliative (P) | 2016-10-04 | 2016-10-04 | Doxorubicin + Ifosfamide | N | N | PACLITAXEL | 100255018 |
| 160016454 | 160008164 | 1.79 | 74.5 | Neo-adjuvant (N) | 2019-04-02 | 2019-04-10 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101601332 |
| 160016456 | 160008165 | 1.63 | 57 | null | 2017-06-14 | 2017-06-14 | Pazopanib | N | N | LIPOSOMAL DOXORUBICIN | 101513883 |
| 160016457 | 160008166 | 1.83 | 79.3 | Neo-adjuvant (N) | 2017-08-30 | 2017-08-30 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100492848 |
| 160016458 | 160008167 | 1.59 | 113 | Palliative (P) | 2016-11-04 | 2016-11-19 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101305493 |
| 160016462 | 160008168 | 1.75 | 65 | Palliative (P) | 2016-12-25 | 2017-01-10 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101660087 |
| 160016466 | 160008169 | null | 100 | null | 2016-10-11 | 2016-10-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | DOXORUBICIN + OLARATUMAB | 101070952 |
| 160016467 | 160008170 | 1.76 | 63.15 | Neo-adjuvant (N) | null | 2018-04-29 | EP 1 2 or 3 day | 02 | N | EURO-EWING | 100434212 |
| 160016468 | 160008171 | 1.7 | 50 | Neo-adjuvant (N) | 2017-10-04 | 2017-10-11 | Doxorubicin + Olaratumab | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101166820 |
| 160016469 | 160008172 | 1.64 | 79 | Neo-adjuvant (N) | 2017-01-25 | 2017-02-28 | IDARUBICIN | null | N | DOXORUBICIN + OLARATUMAB | 100651498 |
| 160016476 | 160008173 | 1.64 | 82 | null | 2020-09-27 | 2020-10-06 | CYCLOPHOSPHAMIDE | 02 | N | GEMCITABINE + OXALIPLATIN + RITUXIMAB | 101378023 |
| 160016477 | 160008174 | 1.74 | 100 | Palliative (P) | 2019-04-19 | 2019-04-20 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101786150 |
| 160016479 | 160008175 | 1.79 | 83 | Palliative (P) | 2019-05-29 | 2019-06-01 | VIDE | 02 | null | VENETOCLAX | 100294636 |
| 160016480 | 160008176 | 0.8 | null | null | 2018-09-16 | 2018-10-21 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | IMATINIB | 101549128 |
| 160016487 | 160008177 | 1.7 | 73.6 | Adjuvant (A) | 2018-08-17 | 2018-09-11 | NB HRNBL-1 COJEC Ind COURSE A | 2 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 101511330 |
| 160016488 | 160008178 | 1.54 | 74 | null | 2018-05-05 | 2018-05-05 | NB HRNBL-1 COJEC Ind COURSE A | 02 | null | DOXORUBICIN + OLARATUMAB | 100949605 |
| 160016490 | 160008180 | 1.82 | 81.1 | Palliative (P) | 2018-10-17 | 2018-10-18 | Cisplatin + Pemetrexed | Y | N | CISPLATIN + PEMETREXED | 100927704 |
| 160016491 | 160008181 | 0 | 0 | Palliative (P) | 2019-01-03 | 2019-01-29 | Pemetrexed | N | N | DOCETAXEL | 101476716 |
| 160016492 | 160008182 | 1.79 | 90 | Neo-adjuvant (N) | 2017-05-09 | 2017-05-10 | Doxorubicin + Ifosfamide | 02 | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 101692118 |
| 160016494 | 160008183 | 1.69 | 70.8 | Palliative (P) | 2019-07-02 | 2019-07-16 | Cisplatin + Paclitaxel | 02 | N | TRIAL UNSPECIFIED | 100717776 |
| 160016495 | 160008184 | 1.69 | 89.6 | Palliative (P) | 2017-09-30 | 2017-10-17 | Doxorubicin + Olaratumab | 01 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100755110 |
| 160016496 | 160008185 | 1.72 | 46.9 | Palliative (P) | null | 2017-12-29 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 100199683 |
| 160016502 | 160008186 | 1.64 | 79.1 | Curative (C) | 2019-03-02 | 2019-03-10 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101772014 |
| 160016503 | 160008187 | 1.89 | 105.9 | Disease modification (D) | 2016-12-24 | 2016-12-31 | DOXORUBICIN | 2 | N | DOXORUBICIN | 101759217 |
| 160016510 | 160008188 | 1.78 | 82.5 | Palliative (P) | 2017-08-05 | 2017-08-06 | STS Rhabdomyosarcoma RMS 2005 VAVV | 02 | N | DOXORUBICIN + OLARATUMAB | 101787090 |
| 160016511 | 160008189 | 1.85 | 70 | Curative (C) | 2020-04-17 | 2020-04-17 | DABRAFENIB + TRAMETINIB | 02 | N | DACARBAZINE + DOXORUBICIN | 101666070 |
| 160016512 | 160008190 | 1.74 | 64.8 | Palliative (P) | 2018-07-14 | 2018-07-20 | GEMCARBO | 02 | N | PEMETREXED | 101467147 |
| 160016516 | 160008191 | 1.76 | 48.2 | Palliative (P) | 2015-05-16 | 2015-05-16 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100085188 |
| 160016521 | 160008192 | 1.86 | 80 | Palliative (P) | 2019-04-16 | 2019-04-21 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | EW EUROEWING 2012 ARM B VDC | 101579816 |
| 160016522 | 160008193 | null | 86 | Palliative (P) | 2019-08-20 | 2019-08-21 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | null | VINCRISTINE | 101559160 |
| 160016524 | 160008194 | 1.82 | 6.9 | null | 2019-05-14 | 2019-05-20 | Bevacizumab | 02 | N | IMATINIB | 101410906 |
| 160016526 | 160008195 | 1.6 | 65.4 | Neo-adjuvant (N) | null | null | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101319145 |
| 160016528 | 160008196 | 1.56 | 106.7 | null | 2019-09-22 | 2019-09-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | CARBOPLATIN + PACLITAXEL | 101194974 |
| 160016530 | 160008197 | 1.66 | 49.15 | Palliative (P) | 2018-01-30 | 2018-02-02 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 101066328 |
| 160016540 | 160008198 | 1.66 | 83.9 | Palliative (P) | 2020-02-22 | 2020-03-08 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101003034 |
| 160016541 | 160008199 | 1.69 | null | Curative (C) | 2017-02-07 | 2017-02-11 | ICON8B TRIAL | null | N | LIPOSOMAL DOXORUBICIN | 100125749 |